Cardio-Phoenix News & Updates

Explore our latest announcements, insights, event highlights, published research, and real-world use cases of Cardio-HART.

Insights
NT-proBNP in Heart Failure Diagnosis: Challenges, Clinical Effectiveness, and the Need for More Accurate Tools
May 22, 2025
Abstract N-terminal pro B-type natriuretic peptide (NT-proBNP) has long been used as a biomarker for diagnosing heart failure (HF), especially in emergency settings. However, its…
Read More
Events
Cardio-Phoenix at the British Society for Heart Failure (BSH) 27th Annual Meeting
December 20, 2024
Dates: November 21–22, 2024, London, UK Our team at Cardio-Phoenix had the privilege of participating in the 27th Annual Meeting of the British Society for…
Read More
Events
Cardio-Phoenix: Advancing Early Detection in First-Level Care at SEC 2024 Congress
December 17, 2024
Dates: October 24–26, 2024 | Bilbao, Spain Our team at Cardio-Phoenix was honored to participate in the Spanish Society of Cardiology (SEC) 2024 Congress on Cardiovascular Health,…
Read More
Events
Exploring the Connection Between Diabetes and Cardiovascular Health at DPC 2024
December 12, 2024
Dates: October 15–16, 2024 | Olympia London, UK Cardio-Phoenix was honored to be invited to the Diabetes Professional Care conference in London. This integrated event…
Read More
Announcement
Major Updates in Cardio-HART: Enhancing Precision and User Experience
June 25, 2024
The latest updates to Cardio-HART, in particular the CE Certified CHART Processing Algorithm (CPA) bring several improvements designed to enhance diagnostic accuracy, user experience, and…
Read More
Insights
Cardio-HART and QTc
April 26, 2024
CHART and QTc Introduction The Cardio-HART (CHART) system assesses the QT interval as part of a comprehensive 12-lead ECG interpretation. CHART is specifically designed to…
Read More

Categories

What makes Cardio-HART a game-changer in early cardiac diagnostics?

Cardio-HART redefines how heart conditions are detected by combining advanced biosignal analysis with AI. Instead of relying solely on ECG, it captures a deeper view of the heart’s mechanical and electrical functions — enabling primary care physicians to detect complex heart diseases earlier, without waiting for specialist referrals.

How does Cardio-HART differ from traditional ECG in real-world studies?

Unlike ECG, Cardio-HART uses AI-driven algorithms combining ECG, PCG, and MCG signals to detect structural and functional heart disorders with higher sensitivity — as validated in multiple studies.

Where has Cardio-HART been presented or featured?

Cardio-HART has been presented at major European cardiology congresses and scientific publications. See our Events and Publications sections for more.

FAQ –>